Literature DB >> 17077657

Immunologic and clinical manifestations of infectious scleritis after pterygium excision.

Chuan-Yi Su1, Jih-Jin Tsai, Yo-Chen Chang, Chang-Ping Lin.   

Abstract

PURPOSE: To present the immunologic status and clinical manifestations of patients who had infectious scleritis after pterygium excision.
METHODS: This prospective noncomparative study of immunologic status and clinical manifestations involved 18 eyes of 18 patients with infectious scleritis (16 bacterial and 2 fungal infections) with a history of pterygium excision from 1999 to 2001.
RESULTS: The period between pterygium excision and scleritis ranged from 1 to 36 years. None of the 18 patients had any history of systemic autoimmune disease. Elevated erythrocyte sedimentation rates were found in 9 (50%) of 18 patients. Elevated serum C-reactive protein levels were found in 9 (75%) of 12 patients. Other serologic tests were all negative. The most common pathogen of infectious scleritis, Pseudomonas aeruginosa, was present in 13 patients (72.2%), significantly higher than any others (P < 0.05). All of the eyeballs were salvaged, and 9 (50%) of 18 patients had final vision better than 2/20.
CONCLUSION: There was no underlying autoimmune disease associated with infectious scleritis in this study. Early diagnosis and aggressive medical and surgical treatment might have saved the eyes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077657     DOI: 10.1097/01.ico.0000214228.44109.0f

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  10 in total

1.  Novel antibiotic regime for pseudomonal scleritis complicating scleral buckling surgery.

Authors:  Deric De Wit; Douglas Newman
Journal:  BMJ Case Rep       Date:  2010-04-29

2.  Prophylactic removal and microbiological evaluation of calcified plaques after pterygium surgery.

Authors:  Tai Jun Kim; Hyuk Jin Choi; Mee Kum Kim; Won Ryang Wee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-15       Impact factor: 3.117

3.  Interventions and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year Perspective.

Authors:  Sumayya Ahmad; Michelle Lopez; Marwan Attala; Anat Galor; Natalie A Stanciu; Darlene Miller; Leejee Suh; Thomas Albini; Victor L Perez; Carol L Karp; Janet L Davis; Eduardo Alfonso; Richard K Forster; Guillermo Amescua
Journal:  Ocul Immunol Inflamm       Date:  2017-10-17       Impact factor: 3.070

4.  Management and outcome of microbial anterior scleritis.

Authors:  Matthew A Cunningham; Jamie K Alexander; Alice Y Matoba; Dan B Jones; Kirk R Wilhemus
Journal:  Cornea       Date:  2011-09       Impact factor: 2.651

5.  Pseudomonas aeruginosa Scleritis following Pterygium Surgery with Mitomycin C or Beta Irradiation: Three-Case Report.

Authors:  Winai Chaidaroon; Somsanguan Ausayakhun; Napaporn Tananuvat; Phit Upaphong; Kittipong Thabsuwan
Journal:  Case Rep Ophthalmol Med       Date:  2022-05-05

6.  Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population.

Authors:  Seong Joon Ahn; Joo Youn Oh; Mee Kum Kim; Jin Hak Lee; Won Ryang Wee
Journal:  Korean J Ophthalmol       Date:  2010-11-23

7.  Clinico-microbiological profile and treatment outcome of infectious scleritis: experience from a tertiary eye care center of India.

Authors:  Srikant Kumar Sahu; Sujata Das; Savitri Sharma; Kalyani Sahu
Journal:  Int J Inflam       Date:  2011-11-20

8.  Risk factors and clinical outcomes of bacterial and fungal scleritis at a tertiary eye care hospital.

Authors:  Jagadesh C Reddy; Somasheila I Murthy; Ashok K Reddy; Prashant Garg
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

Review 9.  Clinical characteristics and visual outcomes in infectious scleritis: a review.

Authors:  Emeline Radhika Ramenaden; Veena Rao Raiji
Journal:  Clin Ophthalmol       Date:  2013-11-04

10.  Experience of scleritis and episcleritis at a tertiary center in Southern Taiwan.

Authors:  Yun-Wen Chen; Yi-Chieh Poon; Hun-Ju Yu; Ming-Tse Kuo; Po-Chiung Fan
Journal:  Taiwan J Ophthalmol       Date:  2015-01-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.